pyridoxal phosphate has been researched along with mrs2159 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, JH; Jung, KY; Kim, HJ; Kim, YC; Lee, JS | 1 |
| Cornelissen, H; De Vos, R; Hoylaerts, MF; Oury, C; Sticker, E; Vermylen, J | 1 |
| Marks, DC; Mullany, PR; Sluyter, R; Sophocleous, RA; Winter, KM | 1 |
| Boyden, ES; Hernández-Vivanco, A; Martín-Fernández, M; Mederos, S; Navarrete, M; Perea, G; Ramírez-Franco, J; Yang, A | 1 |
4 other study(ies) available for pyridoxal phosphate and mrs2159
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of carboxylic acid derivatives of pyridoxal as P2X receptor antagonists.
Topics: Carboxylic Acids; Dose-Response Relationship, Drug; Humans; Molecular Structure; Purinergic P2X Receptor Antagonists; Pyridoxal; Receptors, Purinergic P2X3; Structure-Activity Relationship | 2013 |
ATP augments von Willebrand factor-dependent shear-induced platelet aggregation through Ca2+-calmodulin and myosin light chain kinase activation.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Azo Compounds; Blood Platelets; Blotting, Western; Calcium; Calmodulin; Collagen; Cytoskeleton; Enzyme Activation; Flow Cytometry; Humans; Immunoblotting; Ions; Microscopy, Electron; Models, Biological; Myosin-Light-Chain Kinase; P-Selectin; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Protein Binding; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2X; Thrombin; Time Factors; von Willebrand Factor | 2004 |
Propensity of red blood cells to undergo P2X7 receptor-mediated phosphatidylserine exposure does not alter during in vivo or ex vivo aging.
Topics: Adamantane; Adenosine Triphosphate; Aminoquinolines; Annexin A5; Azo Compounds; Benzenesulfonates; Blood Preservation; Cellular Senescence; Erythrocyte Membrane; Humans; Membrane Lipids; Osmotic Fragility; Phosphatidylserines; Purinergic P2X Receptor Antagonists; Pyridines; Pyridoxal Phosphate; Receptors, Purinergic P2X1; Receptors, Purinergic P2X7; Tetrazoles | 2015 |
Melanopsin for precise optogenetic activation of astrocyte-neuron networks.
Topics: 2-Amino-5-phosphonovalerate; Adenosine A2 Receptor Antagonists; Alanine; Animals; Astrocytes; Azo Compounds; Channelrhodopsins; Chelating Agents; Egtazic Acid; Excitatory Amino Acid Antagonists; Glial Fibrillary Acidic Protein; Hippocampus; Inositol 1,4,5-Trisphosphate Receptors; Light; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Net; Neurons; Optogenetics; Pyridoxal Phosphate; Pyrimidines; Rod Opsins; Synaptic Potentials; Triazoles; Xanthenes | 2019 |